Preliminary results of a multicenter study for home treatment of pulmonary embolism (PE)

R. Otero, A. Cayuela, F. Uresandi, M. A. Cabezudo, D. Jimenez, M. Oribe, D. Nauffal, F. Conget, E. Laserna, the Cooperative Group for Home Treatment of Pulmon (Seville, Bilbao, Oviedo, Madrid, Galdakao, Valencia, Zaragoza, Bormujos, Spain)

Source: Annual Congress 2006 - Pulmonary embolism
Session: Pulmonary embolism
Session type: Oral Presentation
Number: 2187
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Otero, A. Cayuela, F. Uresandi, M. A. Cabezudo, D. Jimenez, M. Oribe, D. Nauffal, F. Conget, E. Laserna, the Cooperative Group for Home Treatment of Pulmon (Seville, Bilbao, Oviedo, Madrid, Galdakao, Valencia, Zaragoza, Bormujos, Spain). Preliminary results of a multicenter study for home treatment of pulmonary embolism (PE). Eur Respir J 2006; 28: Suppl. 50, 2187

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A multicentre observational study of the prevalence, management and outcomes of subsegmental pulmonary embolism
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020


Pulmonary embolism in the multicentre advanced study for a thromboembolism registry (MASTER): study design and patients recruited
Source: Eur Respir J 2005; 26: Suppl. 49, 595s
Year: 2005

Maintenance after pulmonary rehabilitation in COPD: a randomised trial. Preliminary results
Source: Eur Respir J 2004; 24: Suppl. 48, 245s
Year: 2004

Prognostic factors of pulmonary embolism: results of a prospective multicenter study
Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease
Year: 2008

Hemodynamics and response to therapy of pulmonary hypertension in patients with interstitial lung disease: Preliminary results of the "HYPID" prospective study
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012

Safety of riociguat for chronic thromboembolic pulmonary hypertension (CTEPH): Interim data from a prospective non-interventional study in Japan
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018


Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism
Source: Eur Respir J, 51 (4) 1702505; 10.1183/13993003.02505-2017
Year: 2018



Impact of patients’ setting on the prevalence of pulmonary embolism in acute exacerbation of COPD : a meta-analysis of observational studies.
Source: International Congress 2017 – Pulmonary embolism
Year: 2017

Prevalence of chronic thrombo-embolic pulmonary hypertension after pulmonary embolism: A prospective multicenter study
Source: Annual Congress 2010 - Pulmonary hypertension updates
Year: 2010


Preliminary results of a prospective, multicentric randomized study comparing Interferon Gamma-1b (IFN-γ) and colchicine in the treatment of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2003 - Interstitial lung diseases
Year: 2003


Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension (CTEPH) as early follow-up treatment after pulmonary endarterectomy (PEA) – a prospective cohort study
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Use of bosentan for the treatment of pulmonary arterial hypertension in Spain: a multicenter, retrospective, observational study
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009

Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study
Source: ERJ Open Res, 7 (3) 00379-2021; 10.1183/23120541.00379-2021
Year: 2021



Diagnosis of pulmonary embolism by chest ultrasound. A prospective multicenter study
Source: Eur Respir J 2004; 24: Suppl. 48, 69s
Year: 2004

Early discharge of patients with pulmonary embolism: a two-phase observational study
Source: Eur Respir J 2007; 30: 708-714
Year: 2007



PULSAR open-label extension: interim results from a phase 2 study of the efficacy and safety of sotatercept when added to standard of care for the treatment of pulmonary arterial hypertension (PAH)
Source: Virtual Congress 2021 – All about pulmonary arterial hypertension
Year: 2021



Preliminary results of pulmonary rehabilitation in interstitial lung diseases: A randomised controlled trial B32220095560
Source: Annual Congress 2011 - Exercise training: new populations, new techniques
Year: 2011


Prevalence of pulmonary embolism in patients with isolated syncope in the emergency department: the PEEPS multicenter prospective cohort study.
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019

Macitentan for inoperable chronic thromboembolic pulmonary hypertension (CTEPH): results from the randomised controlled MERIT study
Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials
Year: 2017



LATE-BREAKING ABSTRACT: COPD-associated severe pulmonary hypertension (COPDPH): results of a 16-weeks prospective multicenter, double-blind, placebo-controlled randomized clinical trial (RCT) [SPHERIC-1 (http://clinicaltrials.gov/ct2/show/NCT01441934)] investigating the effect of sildenafil citrate (Sld) on pulmonary vascular resistance (PVR) and PaO2.
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013